New Carcinotech funding to expand tumor 3D printing commercialization
Edinburgh-based tumor 3D printing specialists Carcinotech has successfully raised £4.2 million in an investment round led by Eos Advisory (Eos) and the Investment Fund for Scotland (IFS).